𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Depression in Parkinson's disease: biogenic amines in CSF of “de novo” patients

✍ Scribed by W. Kuhn; Th. Müller; M. Gerlach; E. Sofic; G. Fuchs; N. Heye; R. Prautsch; H. Przuntek

Publisher
Springer
Year
1996
Tongue
English
Weight
301 KB
Volume
103
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Depression in patients with Parkinson's
Depression in patients with Parkinson's disease
✍ Jeffrey L. Cummings; Donna L. Masterman 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Parkinson's disease (PD) is a disabling neurodegenerative condition commonly complicated by the existence of comorbid depression. The prevalence rates of depression in this patient group have been reported to be as high as 40%. Currently, depression in PD is undertreated; there have been few control

Decision making in de novo Parkinson's d
Decision making in de novo Parkinson's disease
✍ Michele Poletti; Daniela Frosini; Claudio Lucetti; Paolo Del Dotto; Roberto Cera 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

## Abstract The aim is to study decision making in patients with de novo Parkinson's disease (PD). Recent studies reported that medicated patients with PD have poor performances compared with age‐matched healthy controls in decision making tasks, specially in the Iowa Gambling Task. Two principal c

Grip force abnormalities in de novo Park
Grip force abnormalities in de novo Parkinson's disease
✍ Stuart J. Fellows; Johannes Noth 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

## Abstract In recent years it has been shown that a variety of movement disorders are associated with abnormalities of the fine motor control of the hand. In Parkinson's disease (PD), these changes consist of a slowing of the rate of grip force development and the use of abnormally large grip forc

Depressive symptom profile in Parkinson'
Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease
✍ Uwe Ehrt; Kolbjørn Brønnick; Albert F. G. Leentjens; Jan Petter Larsen; Dag Aars 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 1 views

## Abstract ## Objective Depression is a common neuropsychiatric syndrome in Parkinson's disease (PD), and may be etiologically related to the neurochemical changes accompanying this disease. It is still unclear whether the disturbances of neurotransmitter activities lead to a specific profile of

Trial of subtherapeutic pergolide in de
Trial of subtherapeutic pergolide in de novo Parkinson's disease
✍ Katherine Grosset; Donald Grosset; Andrew Lees 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

## Abstract The effect of pergolide 25 μg twice daily on levodopa initiation was assessed in a randomized, placebo‐controlled, parallel group, double‐blind multicenter trial in 106 untreated early Parkinson's disease patients. The primary endpoint of mean time until levodopa was 520 days (95% confi

Increased alpha activity in REM sleep in
Increased alpha activity in REM sleep in de novo patients with Parkinson's disease
✍ Thomas C. Wetter; Hans Brunner; Birgit Högl; Alexander Yassouridis; Claudia Tren 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

## Abstract We compared the sleep structure including a quantitative electroencephalographic (EEG) analysis and the frequency of periodic limb movements (PLM) in 17 patients with Parkinson's disease (PD; 10 men, seven women, mean age 65.9 years, mean Hoehn and Yahr stage 1.8) who had never been tre